Viewing SEC Facts Units
Company Name:
Revance Therapeutics, Inc.
CIK:
1479290
Start Filing Date:
2023-04-01
End Filing Date:
2023-06-30
ACCN:
0001479290-23-000093
Value:
$ 900,000
Value Error:
$ None
Created By:
Date Filed:
2023-08-08
FY:
2023
Fiscal Period:
Q2
Frame:
CY2022Q2
Type:
us-gaap
Form:
10-Q
Units:
USD